Notes on Materials Storage and Purification
Dulbecco`s phosphate-buffered saline (PBS, 10 mM) was purchased from Biowest (w/o Mg and w/o Ca ions; Product Code: L0615), or freshly prepared in our laboratories according to the technical specification sheet from Dulbecco ® , and stored at room temperature. PBS used for UV-vis experiments was degassed and stored under nitrogen. Magnesium-and fatty acids-free bovine serum albumin (BSA) was purchased from SERVA electrophoresis GmbH, and stored at -20 °C. Thallium(I) ethanolate (Alfa Aesar©) was stored under argon at -20 °C, protected from light. Due to the high instability towards hydrolysis, this compound was used no longer than a month from purchase. Dried and degassed dichloromethane (CH 2 Cl 2 ) and n-hexane were obtained from an MBRAUN solvent purification system (MB SPS-800) and stored under nitrogen over molecular sieves (4 Å). Tetrahydrofuran (THF) was dried over Na/benzophenone, freshly distilled prior to use and stored under nitrogen over molecular sieves (4 Å). Pyridine and dimethylsulfoxide (DMSO) were degassed with nitrogen, dried over CaH 2 , freshly distilled prior to use and stored under nitrogen over molecular sieves (4 Å). Ethanol was degassed with nitrogen, dried over magnesium, freshly distilled prior to use and stored under nitrogen atmosphere over molecular sieve (4 Å), for the synthesis of 2. Alternatively, ethanol was distilled, and the EtOH/H 2 O 3:2 (v/v) mixture for the synthesis of 7, was degassed and stored under argon. BSA stock solutions in PBS were stored at 4 °C in the dark.
Syntheses
closo-1-(Quinolin-8-yl-acetate)-1,2-C 2 B 10 H 101 (6) 6 was synthesised in an analogous way as described for 4 and 5, from 1 (500 mg, 2.47 mmol, 1.0 eq.), 8-hydroxyquinoline (449 mg, 3.09 mmol, 1.25 eq.), Boc 2 O (0.85 mL, 809 mg, 3.71 mmol, 1.5 eq.) and NaNH 2 (121 mg, 3.09 mmol, 1.25 eq.). Purification of the crude product was carried out as follows. The reaction mixture was diluted with CH 2 Cl 2 (25 mL) and transferred to a separation funnel. The organic phase was washed with water (2 x 25 mL) and sat. aq. NaHCO 3 (2 x 25 mL). The water phase was extracted with CH 2 Cl 2 (2 x 25 mL), and the combined organic phases were dried over MgSO 4 . Celite was added and the volatiles were removed with a rotary evaporator. The product was purified via silica-gel column chromatography (length = 13 cm; diameter = 3.5 cm), using n-hexane/ethyl acetate 1:1 → 1:3 (v/v), then acetone. The frac on containing 6 (R f = 0.18, n-hexane/ethyl acetate 1:1 (v/v)) was evaporated to dryness, and the residue was recrystallised twice from hot n-hexane (50 °C), yielding 6 as a colourless powder (152 mg, 19%) . 6 is air-stable in the solid state, but the ester bond slowly hydrolyses in wet acetone or DMSO solutions in air (colour change from yellow to dark green). (CDCl 3 ) : δ (ppm) = -2.2 (1B, s), -5.1 (1B, s), -9.4 (2B, s), -10.5 (2B, s), -12.0 (2B, s), -12.9 (2B, s).
11
B NMR (CDCl 3 ): δ (ppm) = -2.2 (1B, d, 1 J BH = 149 Hz), -5.1 (1B, d, 1 J BH = 140 Hz), -9.3 (2B, d, 1 J BH = 147 Hz), -11.8 (2B, d, 1 J BH = 141 Hz), -13.1 (2B, d, 1 J BH = 122 Hz). 1 13 C{ 1 H} NMR (CDCl 3 ): δ (ppm) = 42.5 (s, C 1 ), 58.5 (s, C cluster -H), 66.6 (s, C cluster -H), 83.4 (s, C 7 ), 94.9 (s, C 11 ), 98.6 (s, C 3 ), 110.0 (s, C 4 ), 117.9 (s, C 6 ), 121.8 (s, C 5 ), 127.8 (s, C 9 ), 136.2 (s, C 8 ), 147.8 (s, C 10 ), 166.5 (s, C 2 ). ESI-MS(+): m/z = 354.8611 (100%, [M+Na] + ).
rac-Na[nido-7-(quinolin-8-yl-acetate)-7,8-C 2 B 9 H 11 ] (7)
7 was synthesised in an analogous way as described for Na[2], from 6 (100 mg, 0,30 mmol, 1.0 eq.) and NaF (66 mg, 1.57 mmol, 5.23 eq.). 7 (79 mg, 64%) was obtained as air-stable, bright yellow powder. 7 is soluble in acetonitrile, acetone and DMSO. 1 Not all 1 J BH constants could be determined, due to extensive overlapping of 11 B signals. 2 endo-H is the fluxional extra proton on the C 2 B 3 face of the nido-carborane(-1) derivatives. 3 α and β indicate the two cluster-bound methylene protons.
S4

Reaction of 7 with [{(η 6 -p-cymene)RuCl(μ-Cl)} 2 ]
Method A. 7 (115 mg, 0.36 mmol, 1.0 eq.) was dissolved in dry THF (8 mL) and cooled to -30 °C, under argon atmosphere and protected from light. TlOEt (53.9 μL, 189.7 mg, 0.76 mmol, 2.1 eq.) was added in one portion, and the mixture was stirred at -30 °C for 30 min, then for 2 h at room temperature. The solution was concentrated in vacuo, to a volume of ca. 2 mL. NMR analysis (CDCl 3 ) of the reaction mixture showed quantitative deprotonation of 7 to its dithallium salt (Tl[Tl7]), without cleavage of the ester bond ( Figure S2 and Figure S3 ). The rest of the solvent was evaporated in vacuo, yielding a bright yellow residue, which was washed with EtOH (2 x 2 mL), filtered and dried in vacuo. [{(η 6 -pcymene)RuCl(μ-Cl)} 2 ] (110 mg, 0.18 mmol, 0.5 eq.) was added to the Tl[Tl7] salt, the reaction flask was cooled to -65 °C, and degassed CH 2 Cl 2 (10 mL) was added. The reaction mixture was left stirring to warm up to room temperature over 16 h. The reaction mixture was then filtered, and the precipitate was identified via NMR spectroscopy as chlorido(8-quinolinato-κ 2 N,O)(η 6 -pcymene)ruthenium(II) ( Figure S1 ). The filtrate was purified via column chromatography on silica gel (dry load with celite), yielding pure complex 3. The desired ester-substituted ruthenacarborane complex could not be isolated.
Method B. Alternatively, 7 (375 mg, 1.18 mmol, 1.0 eq.) was reacted with lithium bis(trimethylsilyl)amide (LiHMDS, 1M sol. in THF, 1.42 mL, 1.42 mmol, 1.2 eq.), as base, at -78 °C for 1 h, then at room temperature for 40 min. After solvent removal and washing with n-hexane (5 mL), the Na[Li7] salt was redissolved in 11 mL THF, cooled to -78 °C, and [{(η 6 -p-cymene)RuCl(μ-Cl)} 2 ] (362 mg, 0.59 mmol, 0.5 eq.) was added in one portion. After 40 min, the cooling bath was removed, and the mixture was left stirring at room temperature for 15 h. The ensuing precipitate was identified once again as chlorido(8-quinolinato-κ 2 N,O)(η 6 -p-cymene)ruthenium(II). The filtrate was purified via inert column chromatography on silica gel, yielding only complex 3.
Biological Studies
Reagents and Cells. Fetal calf serum (FCS), phosphate-buffered saline (PBS), dimethylsulfoxide (DMSO), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), carboxyfluoresceinsuccinimidyl ester (CFSE), 3-methyladenine (3-MA), chloroquine (CQ) diphosphate salt, crystal violet (CV) and acridine orange (AO) were obtained from Sigma Aldrich (St. Louis, MO, USA). 4′,6-diamidino-2-phenylindole (DAPI) was from Fluoromounth-G (Southern Biotech., Birmingham, AL, USA). Cell culture medium RPMI-1640 was from Biowest (Riverside, MO, USA), while Dulbecco's Modified Eagle Medium (DMEM) was from Biological Industries (Cromwell, CT, USA). Annexin V-FITC (AnnV) was from BD Pharmingen (San Diego, CA,USA), while ApoStat was bought from R&D Systems (Minneapolis, MN, USA). Cell lines (human skin melanoma A375, mouse melanoma B16, human breast adenocarcinoma MCF-7, human normal fibroblasts MRC-5, human malignant glioblastoma LN229 and glioma U251) were purchased from the American Type Culture Collection (ATCC, Manassas, Virginia, USA), while mouse microglial cell line BV-2 was a kind gift from Dr. Irena Lavrnja, Institute for Biological Research "Siniša Stanković" (University of Belgrade). Cells were routinely cultivated in HEPES-buffered RPMI-1640 (A375, B16, MCF-7, MRC-5, BV-2) or DMEM (U251, LN229) medium, supplemented with 10%-FCS, 2 mM L-glutamine, 0.01% sodium pyruvate and antibiotics, at 37 °C in a humidified atmosphere with 5% CO 2 . Peritoneal resident macrophages (Mph) were collected from C57BL/6 mice, obtained from the animal facility at the Institute for Biological Research "Siniša Stanković" (University of Belgrade), via peritoneal lavage with ice-cold PBS. Cells were counted and seeded in 96-well plates and incubated overnight, as described above. Before treatment, non-adherent cells were removed. Isolation of cells from animals were performed in accordance to local guidelines and approved by the local Institutional Animal Care and Use Committee (IACUC).
Staining Protocols for Flow Cytometric Analysis. For AnnV/PI, AO and ApoStat staining, cells were treated with an IC 50 dose of 3 or 4 for 72 h, then detached with trypsin and washed with PBS. In the case of Ann/PI double staining and Apostat, cells were stained according to the manufacturer's protocols. Cells were incubated with AnnV and PI in Ann-binding buffer (15 µg mL -1 ; 15 min, room temperature)., or ApoStat (ZVAD-FMK-FITC, 1 µL) in PBS (30 min, 37 °C). For detection of acidic vacuoles, upon treatment cells were stained with AO dye (1 μg mL −1 ; 15 min, 37 °C), in PBS. Finally, cells were washed in PBS, resuspended in PBS (or AnnV-binding buffer for AnnV/PI), and analysed. For CFSE staining, detached cells were first stained with a PBS solution of CFSE (1 μM; 10 min, 37 °C), then washed, seeded and then exposed to an IC 50 dose of 3 or 4 for 72 h. Cells were then washed, trypsinised, dissolved in PBS and analysed by CyFlow® Space Partec using the PartecFloMax® software (Partec GmbH, Münster, Germany).
Staining Protocols for Fluorescence Microscopy. To evaluate the presence of apoptosis, cells were seeded in 8-chamber slides at 1.5 × 10 4 cells/well and treated with an IC 50 dose of 3 and 4 for 72 h. At the end of the incubation period, cells were fixed with 4% (w/v) paraformaldehyde for 15 min at room temperature, washed and covered with DAPI fluoromounth-G (Southern Biotech, Birmingham, AL, USA), before analysis. Slides were analysed with Zeiss AxioObserver Z1 inverted fluorescence microscope (Carl Zeiss AG, Oberkochen, Germany) at 400× magnification. Morphological signs of apoptosis (irregular nuclei shape, condensed chromatin, apoptotic bodies) were examined by three independent observers.
Wound Healing Assay. For evaluation of the cells' motility, wound healing assay, in which cells migrate bidirectionally from the edges of a scratch wound, was used. Cells were seeded in 6-well plates, till reaching the confluence, when scratch over cellular layer was drawn with a sterile pipette tip across the centre of the wells to make a clean wound area. Cells were washed twice with fresh PBS to remove loose or damaged cells, and then exposed to an IC 50 dose of 3 and 4 for 72 h. At the end of the incubation period, cells were washed, fixed with 4% (w/v) paraformaldehyde for 10 min and stained with 2% CV solution for 1 min at room temperature. The wounds were digitally photographed using a Moticam 2000 camera and Nikon Digital Sight Fi2 camera attached to a Nikon SMZ800 stereo zoom microscope.
Western Blot Analysis. Cells were incubated with an IC 50 dose of 3 or 4 for 48 and 72 h and lysed in protein lysis buffer (62.5 mM Tris-HCl (pH 6.8 at 25 •C), 2% (w/v) SDS, 10% glycerol, 50 mM dithiothreitol). Electrophoretical separation was done on 15% SDS-polyacrylamide gels. As a protein molecular weight marker, PageRuler prestained ladder (Thermo Scientific, USA) was used. Electrotransfer to polyvinylidenedifluoride membranes at 5 mA cm -2 was done with a semidry blotting system (Fastblot B43; BioRad, Göttingen, Germany). Membranes were blocked with 5% (w/v) BSA in PBS for 1 h at room temperature. Incubation with specific antibodies for the microtubule-associated protein light chain 3B (LC3B) (Sigma Aldrich, St. Louis, MO, USA) or β-actin (Abcam, Cambridge, UK) was done overnight at 4 °C. As a secondary antibody, goat anti-rabbit IgG-horseradish peroxidase (Santa Cruz Biotechnology, Dallas, TX, USA) was used. Bands were detected using a chemiluminescence detection system (ECL; GE Healthcare, Chalfont St. Giles, Buckinghamshire, UK), while the protein levels were determined by densitometry, using ImageJ software (NIH, Bethesda, MD, USA), and expressed relative to β-actin. The results are presented as fold variation in signal intensity relative to the control, that was arbitrarily set to a value of 1. No changes in the 11 B{ 1 H} NMR spectra were observed, signifying that the [RuC 2 B 9 H 10 ] fragment is stable under these conditions. Figure S7 . 1 H NMR spectra (400.13 MHz) of 5 in wet DMSO-d 6 , in air, measured over one month. The second set of signals (second tautomer) for the {4-(7-chloroquinolin-4-yl)oxy}butanol-1-yl group are marked with *. The intensity of these signals is about 5%, with respect to the corresponding signals of 5. Goodness-of-fit on F 2 1.077 1.063 
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